![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/70 | (2006.01) |
A61K 31/7042 | (2006.01) | ||
A61K 31/7052 | (2006.01) | ||
A61K 31/7056 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
C07H 19/052 | (2006.01) |
(11) | Number of the document | 1070078 |
(13) | Kind of document | T |
(96) | European patent application number | 99919169.5 |
Date of filing the European patent application | 1999-04-01 | |
(97) | Date of publication of the European application | 2001-01-24 |
(45) | Date of publication and mention of the grant of the patent | 2003-01-22 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP9902/213 |
Date | 1999-04-01 |
(87) | Number | WO 9905/1617 |
Date | 1999-10-14 |
(30) | Number | Date | Country code |
9807355 | 1998-04-07 | GB |
(72) |
CARTER, Barry, Howard, US
HODGSON, Anne, GB
HUANG, Lian-Feng, US
|
(73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
(54) | FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-BETA-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE |
FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-BETA-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE |